Bain Capital to acquire Mitsubishi Tanabe Pharma from Mitsubishi Chemical for $3.3bn.

Bain Capital, a private investment firm, agreed to acquire Mitsubishi Tanabe Pharma, a pharmaceuticals company, from Mitsubishi Chemical, a chemical products manufacturer, for $3.3bn. “Tanabe Pharma has been delivering innovative medicines to Japanese patients for centuries, and we are proud to partner with MTPC and support its next phase of growth and evolution. As a standalone, independent company, the Company will benefit from the full support of Bain Capital’s global resources and our healthcare team’s extensive experience driving value creation across the healthcare value chain. We look forward to a collaborative partnership with MTPC and helping build a best-in-class Japanese pharma platform,” Masa Suekane, Bain Capital Partner and Head of Japan Healthcare, Industrials and Financial Services at Private Equity.